CBI specializes in complex toxicology programs to generally address unanticipated or unusual toxicologic or pharmacological events, or to conduct tolerability, efficacy or pharmacology studies that are of a novel, unique or unusual nature. These studies are hypothesis-driven and may have specialized or unusual techniques or methods. In some cases, they are requested by the FDA or by clinicians.
Solving your problems is where we are strongest. Our skilled scientists can facilitate protocol development and conduct these novel, difficult and specialized projects.
Custom GLP Study Experience
- Anesthesia-induced cerebral toxicity in neonates
- Intrathecal dosing studies
- Intrathecal dosing toxicity studies in dogs and rodent
- Stem cell toxicity and efficacy, device toxicity studies
- Stereotaxic and intracerebral administration of chemotherapeutic in rodents and dogs
- VX2 tumor combination toxicity and efficacy studies in rabbits
- Wound healing and burn combination toxicity and efficacy studies